Insider Title Company Date Price Return Shares Value
Miller Richard A Md President and CEO Corvus Pharmaceuticals, Inc. (CRVS) 2024-05-06 $1.73 131.1% 577,634 $1,000,000
Miller Richard A Md President and CEO Corvus Pharmaceuticals, Inc. (CRVS) 2022-12-14 $0.75 435.4% 60,000 $44,827
Miller Richard A Md President and CEO Corvus Pharmaceuticals, Inc. (CRVS) 2022-09-28 $0.76 424.4% 25,000 $19,070
Miller Richard A Md President and CEO Corvus Pharmaceuticals, Inc. (CRVS) 2022-09-20 $0.81 392.2% 20,000 $16,253
Miller Richard A Md President and CEO Corvus Pharmaceuticals, Inc. (CRVS) 2022-06-27 $1.01 294.7% 10,000 $10,134
Miller Richard A Md President and CEO Corvus Pharmaceuticals, Inc. (CRVS) 2022-06-06 $0.98 306.4% 5,890 $5,797
Miller Richard A Md President and CEO Corvus Pharmaceuticals, Inc. (CRVS) 2022-03-31 $1.64 144.6% 15,000 $24,534
Miller Richard A Md President and CEO Corvus Pharmaceuticals, Inc. (CRVS) 2022-03-17 $1.49 169.1% 30,000 $44,600
Miller Richard A Md President and CEO Corvus Pharmaceuticals, Inc. (CRVS) 2021-08-20 $1.93 107.7% 10,000 $19,254
Miller Richard A Md President and CEO Corvus Pharmaceuticals, Inc. (CRVS) 2021-05-04 $2.80 42.9% 35,714 $99,999
Miller Richard A Md President and CEO Corvus Pharmaceuticals, Inc. (CRVS) 2021-02-17 $3.50 14.3% 100,000 $350,000
Return Profit / (loss) Cost
Total 117.6% $1,922,483 $1,634,469